Exploring Tumor Sequencing, Antigen Prediction & Validation for Personalized Cancer Vaccines to Develop a Fast & Effective Workflow
Time: 9:30 am
day: Pre-Conference Focus Day
Details:
- Delving into the tumor microenvironment, novel mutational source of neoantigens, and non-canonical antigens in patients to determine the un-utilized antigens for more effective individualized therapies
- Streamlining the sequencing, prediction, and validation of tumor samples for personalized cancer vaccines by a bioinformatics workflow combining public and inhouse developed algorithms
- Verifying the antigens used in individualized therapies in patients’ post-vaccination blood to determine the accuracy of the workflow
